# Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial

> **NCT02024685** · NA · TERMINATED · sponsor: **Case Comprehensive Cancer Center** · enrollment: 76 (actual)

## Conditions studied

- Adenocarcinoma of Prostate
- Adenocarcinoma of the Prostate Stage I
- Adenocarcinoma of the Prostate Stage II
- Adenocarcinoma of the Prostate Stage III

## Interventions

- **BEHAVIORAL:** Personalized Treatment Recommendations
- **BEHAVIORAL:** Standard patient-physician counseling interaction

## Key facts

- **NCT ID:** NCT02024685
- **Lead sponsor:** Case Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-08
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 76 (ACTUAL)
- **Why stopped:** Funding unavailable
- **Last updated:** 2015-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02024685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02024685, "Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02024685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*